Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Tyra Biosciences

Request full access

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs

Carlsbad, United StatesFounded 2018Biotech & Life Sciences

About Tyra Biosciences

Tyra Biosciences is a clinical-stage biotechnology company that develops next-generation precision medicines for oncology and genetically defined diseases. The company's proprietary SNAP platform enables the rapid and precise development of therapies that target specific genetic mutations, aiming to overcome drug resistance and improve treatment outcomes. Tyra's pipeline includes TYRA-300, an FGFR3-selective inhibitor for the treatment of achondroplasia and non-muscle invasive bladder cancer, and TYRA-200, an FGFR1/2/3 inhibitor with a focus on intrahepatic cholangiocarcinoma and other solid tumors.

The company's business model revolves around the research, development, and eventual commercialization of its drug candidates. Tyra Biosciences collaborates with academic institutions and other partners to advance its research and clinical trials. The company generates revenue through venture capital funding and public offerings, with future revenue streams expected from drug sales and licensing agreements upon regulatory approval.

Source: Dealroom company data

At a glance

Status
Operational
Employees
100
Open positions
31
Dealroom signal
93.1/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Precision Medicine, Verified Unicorns and $1B Exits, Post IPO $1B, Biotech and Pharma, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
PRIVATE PLACEMENT VCOther financing Feb 2024 $200M — 5AM Ventures · RA Capital Management · OrbiMed · BVF Partners ↗
IPOOther financing Sep 2021 $199M $626M Undisclosed —
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowthEBITDAMargin
2026 — —
2025 — —
2024 — —
2023 — —
2022 — —
2021 — —
2020 — —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Tyra Biosciences website traffic

Latest recorded traffic for Tyra Biosciences is 10K monthly website visits, up 0% over the last three months. Tyra Biosciences's team grew 26.6% over the past year.

Latest monthly visits10K 3-month web change0% 1-year team growth+26.6%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Tyra Biosciences in the Carlsbad ecosystem

Live from Dealroom

The Tyra Biosciences office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

12 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A10 investors entered at this stage

Other known investors2 additional known investors

Team profiled 6 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Tyra Biosciences on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Tyra Biosciences’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.